vs
NexPoint Real Estate Finance, Inc.（NREF）与AVITA Medical, Inc.（RCEL）财务数据对比。点击上方公司名可切换其他公司
AVITA Medical, Inc.的季度营收约是NexPoint Real Estate Finance, Inc.的1.6倍（$17.6M vs $11.1M），NexPoint Real Estate Finance, Inc.净利率更高（216.6% vs -66.0%，领先282.6%），AVITA Medical, Inc.同比增速更快（-4.3% vs -48.8%）
NexPoint Real Estate Finance, Inc.是一家总部位于美国的商业地产金融企业，主要为多户住宅、写字楼、工业及酒店物业提供结构化融资方案，运营并管理抵押贷款及其他地产相关投资组合，为利益相关方提供经风险调整的稳定回报。
AVITA Medical是一家聚焦再生医学领域的产业化企业，专注于多款再生医疗产品的研发与市场推广。公司首款上市产品ReCell喷雾皮肤产品用于烧伤治疗，最新推出两款产品：面向医美整形领域、用于皮肤损伤修复的ReNovaCell，以及针对慢性伤口治疗的ReGenerCell。目前公司的再生产品管线已在欧洲、中东地区实现商业化销售。
NREF vs RCEL — 直观对比
营收规模更大
RCEL
是对方的1.6倍
$11.1M
营收增速更快
RCEL
高出44.5%
-48.8%
净利率更高
NREF
高出282.6%
-66.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $17.6M |
| 净利润 | $24.0M | $-11.6M |
| 毛利率 | — | 81.2% |
| 营业利润率 | — | -59.1% |
| 净利率 | 216.6% | -66.0% |
| 营收同比 | -48.8% | -4.3% |
| 净利润同比 | 58.7% | -0.3% |
| 每股收益（稀释后） | $0.47 | $-0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NREFRCEL
| Q4 25 | $11.1M | $17.6M | ||
| Q3 25 | $12.5M | $17.1M | ||
| Q2 25 | $12.1M | $18.4M | ||
| Q1 25 | $11.5M | $18.5M | ||
| Q4 24 | $21.7M | $18.4M | ||
| Q3 24 | $12.5M | $19.5M | ||
| Q2 24 | $6.7M | $15.2M | ||
| Q1 24 | $-12.8M | $11.1M |
净利润NREFRCEL
| Q4 25 | $24.0M | $-11.6M | ||
| Q3 25 | $50.9M | $-13.2M | ||
| Q2 25 | $22.3M | $-9.9M | ||
| Q1 25 | $26.0M | $-13.9M | ||
| Q4 24 | $15.2M | $-11.6M | ||
| Q3 24 | $23.3M | $-16.2M | ||
| Q2 24 | $12.1M | $-15.4M | ||
| Q1 24 | $-14.6M | $-18.7M |
毛利率NREFRCEL
| Q4 25 | — | 81.2% | ||
| Q3 25 | — | 81.3% | ||
| Q2 25 | — | 81.2% | ||
| Q1 25 | — | 84.7% | ||
| Q4 24 | — | 87.6% | ||
| Q3 24 | — | 83.7% | ||
| Q2 24 | — | 86.1% | ||
| Q1 24 | — | 86.4% |
营业利润率NREFRCEL
| Q4 25 | — | -59.1% | ||
| Q3 25 | — | -53.6% | ||
| Q2 25 | — | -60.5% | ||
| Q1 25 | — | -63.9% | ||
| Q4 24 | — | -54.1% | ||
| Q3 24 | — | -70.6% | ||
| Q2 24 | — | -102.8% | ||
| Q1 24 | — | -155.0% |
净利率NREFRCEL
| Q4 25 | 216.6% | -66.0% | ||
| Q3 25 | 407.0% | -77.3% | ||
| Q2 25 | 184.5% | -53.9% | ||
| Q1 25 | 225.6% | -74.9% | ||
| Q4 24 | 69.9% | -63.0% | ||
| Q3 24 | 186.4% | -82.9% | ||
| Q2 24 | 179.7% | -101.3% | ||
| Q1 24 | 114.3% | -168.0% |
每股收益（稀释后）NREFRCEL
| Q4 25 | $0.47 | $-0.37 | ||
| Q3 25 | $1.14 | $-0.46 | ||
| Q2 25 | $0.54 | $-0.38 | ||
| Q1 25 | $0.70 | $-0.53 | ||
| Q4 24 | $0.71 | $-0.44 | ||
| Q3 24 | $0.74 | $-0.62 | ||
| Q2 24 | $0.40 | $-0.60 | ||
| Q1 24 | $-0.83 | $-0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $18.2M |
| 总债务越低越好 | $771.2M | — |
| 股东权益账面价值 | $388.0M | $-16.6M |
| 总资产 | $5.3B | $56.4M |
| 负债/权益比越低杠杆越低 | 1.99× | — |
8季度趋势，按日历期对齐
现金及短期投资NREFRCEL
| Q4 25 | $31.1M | $18.2M | ||
| Q3 25 | $17.9M | $23.3M | ||
| Q2 25 | $9.1M | $15.7M | ||
| Q1 25 | $19.2M | $25.8M | ||
| Q4 24 | $3.9M | $35.9M | ||
| Q3 24 | $34.7M | $44.4M | ||
| Q2 24 | $4.3M | $54.1M | ||
| Q1 24 | $13.5M | $68.2M |
总债务NREFRCEL
| Q4 25 | $771.2M | — | ||
| Q3 25 | $720.9M | — | ||
| Q2 25 | $815.6M | — | ||
| Q1 25 | $831.5M | — | ||
| Q4 24 | $799.3M | — | ||
| Q3 24 | $815.5M | — | ||
| Q2 24 | $861.0M | — | ||
| Q1 24 | $843.3M | — |
股东权益NREFRCEL
| Q4 25 | $388.0M | $-16.6M | ||
| Q3 25 | $375.4M | $-6.7M | ||
| Q2 25 | $348.2M | $-12.9M | ||
| Q1 25 | $343.7M | $-4.6M | ||
| Q4 24 | $336.5M | $4.5M | ||
| Q3 24 | $335.8M | $12.2M | ||
| Q2 24 | $327.5M | $23.9M | ||
| Q1 24 | $327.1M | $32.6M |
总资产NREFRCEL
| Q4 25 | $5.3B | $56.4M | ||
| Q3 25 | $5.3B | $63.7M | ||
| Q2 25 | $5.4B | $58.1M | ||
| Q1 25 | $5.4B | $69.6M | ||
| Q4 24 | $5.4B | $79.7M | ||
| Q3 24 | $5.7B | $81.1M | ||
| Q2 24 | $6.6B | $87.8M | ||
| Q1 24 | $7.1B | $97.4M |
负债/权益比NREFRCEL
| Q4 25 | 1.99× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.42× | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 2.43× | — | ||
| Q2 24 | 2.63× | — | ||
| Q1 24 | 2.58× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.5M | $-5.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-6.1M |
| 自由现金流率自由现金流/营收 | — | -34.7% |
| 资本支出强度资本支出/营收 | — | 3.8% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | — | $-33.5M |
8季度趋势，按日历期对齐
经营现金流NREFRCEL
| Q4 25 | $-4.5M | $-5.4M | ||
| Q3 25 | $8.1M | $-5.2M | ||
| Q2 25 | $3.3M | $-10.2M | ||
| Q1 25 | $16.0M | $-10.3M | ||
| Q4 24 | $4.4M | $-8.1M | ||
| Q3 24 | $14.7M | $-7.2M | ||
| Q2 24 | $-7.5M | $-12.8M | ||
| Q1 24 | $17.7M | $-20.9M |
自由现金流NREFRCEL
| Q4 25 | — | $-6.1M | ||
| Q3 25 | — | $-6.2M | ||
| Q2 25 | — | $-10.8M | ||
| Q1 25 | — | $-10.5M | ||
| Q4 24 | — | $-9.7M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-15.4M | ||
| Q1 24 | — | $-22.0M |
自由现金流率NREFRCEL
| Q4 25 | — | -34.7% | ||
| Q3 25 | — | -36.1% | ||
| Q2 25 | — | -58.4% | ||
| Q1 25 | — | -56.9% | ||
| Q4 24 | — | -52.7% | ||
| Q3 24 | — | -56.1% | ||
| Q2 24 | — | -101.6% | ||
| Q1 24 | — | -198.2% |
资本支出强度NREFRCEL
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 8.8% | ||
| Q3 24 | — | 19.2% | ||
| Q2 24 | — | 17.5% | ||
| Q1 24 | — | 10.3% |
现金转化率NREFRCEL
| Q4 25 | -0.19× | — | ||
| Q3 25 | 0.16× | — | ||
| Q2 25 | 0.15× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.63× | — | ||
| Q2 24 | -0.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
